Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule

Published:2015-07-20 Issue:8 Volume:31 Page:1461-1468
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Coleman Craig I.¹²,Kohn Christine G.³,Bunz Thomas J.¹

Affiliation:

1. aUniversity of Connecticut School of Pharmacy, Department of Pharmacy Practice, Storrs, CT, USA

2. bUniversity of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, CT, USA

3. cUniversity of Saint Joseph School of Pharmacy, Hartford, CT, USA

Publisher

Informa Healthcare

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1185/03007995.2015.1062748

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern Treatment Trends and Outcomes of Pulmonary Embolism With and Without Hemodynamic Significance;The Annals of Thoracic Surgery;2020-11

2. Development and Evaluation of a Pharmacist-Driven Screening Tool to Identify Patients Presenting to the Emergency Department Who Are Eligible for Outpatient Treatment of Deep Vein Thrombosis;Journal of Pharmacy Practice;2019-09-05

3. Observation management of pulmonary embolism and agreement with claims-based and clinical risk stratification criteria in United States patients: a retrospective analysis;BMC Pulmonary Medicine;2017-02-13

4. External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veterans;Internal and Emergency Medicine;2017-02-09

5. Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status;International Journal of Clinical Practice;2017-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3